Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a natural fiber cream soothe painful incontinence rashes?

NCT ID NCT07524439

Recruiting now Symptom relief Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a beta-glucan moisturizing cream to standard skin care helps heal incontinence-associated dermatitis faster and reduces symptoms like pain, itching, and burning. Sixty adults with this skin condition will receive either the cream plus standard care or standard care alone for up to two weeks. Researchers will check skin healing, take photos, and ask about discomfort to see if the cream offers extra relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Beta-glucan cream
What this could lead to
If it works, this could provide a simple, gentle cream to speed up healing and ease discomfort for people with incontinence-related skin rashes.
What could go wrong
This is a small early-stage trial with only 60 participants, so results may not apply to everyone. The cream is added to standard care, so any extra benefit may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIAPER RASH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diaper Rash Fecal Incontinence irritant dermatitis Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIAPER RASH FECAL INCONTINENCE IRRITANT CONTACT DERMATITIS IRRITANT CONTACT DERMATITIS CAUSED BY FAECES URINARY INCONTINENCE

Contacts and locations

Locations

  • University of Alberta Hospital

    RECRUITING

    Edmonton, Alberta, T6G2J2, Canada

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.